This study investigated the burden of disease attributable to amphetamine use disorder, cannabis use disorder (CAD), cocaine use disorder, and opioid use disorder (OUD) in South America from 1990 to 2019, on the basis of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019.
We aimed to provide a comparative assessment of global health spending at the onset of the pandemic; characterise the amount of development assistance for pandemic preparedness and response disbursed in the first 2 years of the COVID-19 pandemic; and examine expectations for future health spending and put into context the expected need for investment in pandemic preparedness.
Comparison of health indicators since 1990 provides valuable insights about Pakistan's ability to strengthen its health-care system, reduce inequalities, improve female and child health outcomes, achieve universal health coverage, and meet the UN Sustainable Development Goals.
These estimates highlight where gaps in immunization remain and emphasize the need for broader efforts to strengthen routine immunization systems.
These estimates offer epidemiologically informative detail to better guide more targeted interventions, vital for combating HIV in SSA.
The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 and has provided an updated perspective on the status of cardiovascular health globally, regionally, and nationally.
India’s DAH allocation strategy prioritizes contributions toward neighboring countries in the South Asia region in several health focus areas.
Here, we detail the updated Spain 1990–2019 burden of disease estimates and project certain metrics up to 2030.
We synthesise subnational estimates of the burden of lower respiratory infections, diarrhoea, and malaria in children under-5 from 2000 to 2017 for 43 sub-Saharan countries.
We aimed to examine the levels and trends in the fatal and non-fatal TB burden in Cambodia from 1990 to 2019, assessing progress towards the WHO End TB interim milestones, which aim to reduce TB incidence rate by 20% and TB deaths by 35% from 2015 to 2020.
We estimated deaths associated with 33 bacterial genera or species across 11 infectious syndromes in 2019 using methods from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD).
The findings of the study include points of unanimous agreement, as well as six recommendations with >5% disagreement, that provide health and social policy actions to address inadequacies in the pandemic response and help to bring this public health threat to an end.
The estimated prevalence of all AMD remains high, although vision-threatening late stages appear to be level with past estimates; state and county estimates may be used for public health planning.
The age distribution of a population is important for understanding the demand and provision of labor and services, and as a denominator for calculating key age-specific rates such as fertility and mortality.
We used verbal autopsy and vital registration data to model the proportion of venomous animal deaths due to snakes by location, age, year, and sex, and applied these proportions to venomous animal contact mortality estimates from the Global Burden of Disease 2019 study.
As part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we estimated global trends in, and prevalence of, benign prostatic hyperplasia and disability-adjusted life-years (DALYs) due to benign prostatic hyperplasia, in 21 regions and 204 countries and territories from 2000 to 2019.
This study presents the most comprehensive set of regional and country-level estimates of AMR burden in the WHO European region to date
Long-term analyses of disease burden provide insights on Indonesia’s advance to universal health coverage and its ability to meet the United Nations Sustainable Development Goals by 2030.
We conducted a systematic review and implemented a meta-regression to evaluate the relationships between unprocessed red meat consumption and six potential health outcomes.
We applied a Bayesian meta-regression tool to estimate the mean risk function and quantify the quality of evidence for associations between vegetable consumption and ischemic heart disease (IHD), ischemic stroke, hemorrhagic stroke, type 2 diabetes and esophageal cancer.
We present a new suite of meta-analyses—termed the Burden of Proof studies—designed specifically to help evaluate the effects of exposure to risks objectively and quantitatively.
Using data from published observational studies and controlled trials, we estimated the mean SBP–IHD dose–response function and burden of proof risk function (BPRF), and we calculated a risk outcome score (ROS) and corresponding star rating (one to five).
We re-estimated the dose–response relationships between current smoking and 36 health outcomes by conducting systematic reviews up to 31 May 2022, employing a meta-analytic method that incorporates between-study heterogeneity into estimates of uncertainty.
Among individuals who had symptomatic SARS-CoV-2 infection in 2020 and 2021, what proportion experienced common self-reported Long COVID symptom clusters 3 months after initial infection?
Drawing from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019), we measured the Healthcare Access and Quality (HAQ) Index overall and for select age groups in 204 locations from 1990 to 2019.